Sohliya, Aibannehbok E. L. “Revumenib: The Newly Approved Food Drug Administration Drug for the Treatment of Relapsed Acute Leukemia With a KMT2A Translocation”. International Journal of Research in Medical Sciences 13, no. 2 (January 30, 2025): 987–988. Accessed September 30, 2025. https://www.msjonline.org/index.php/ijrms/article/view/14638.